Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Conditions:   Acute Lymphoblastic Leukemia;   Philadelphia Chromosome-Positive Interventions:   Drug: Blinatumomab;   Procedure: Bone marrow aspiration and biopsy (BMA);   Drug: corticosteroids Sponsors:   Memorial Sloan Kettering Cancer Center;   Amgen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials